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ABSTRACT Upon infection of animal cells by Sindbis
virus, four nonstructural (ns) proteins, termed nsPl-4 in order
from 5' to 3' in the genome, are produced by posttranslational
cleavage of a polyprotein. nsP4 is believed to function as the
viral RNA polymerase and is short-lived in infected cells. We
show here that nsP4 produced in reticulocyte lysates is de-
graded by the N-end rule pathway, one ubiquitin-dependent
proteolytic pathway. When the N-terminal residue of nsP4 is
changed by mutagenesis, the metabolic stabilities of the mutant
nsP4s follow the N-end rule, in that the half-life ofnsP4 bearing
different N-terminal residues decreases in the order Met > Ala
> Tyr 2 Phe > Arg. Addition of dipeptides Tyr-Ala, Trp-Ala,
or Phe-Ala to the translation mixture inhibits degradation of
Tyr-nsP4 and Phe-nsP4, but not of Arg-nsP4. Conversely,
dipeptides His-Ala, Arg-Ala, and Lys-Ala inhibit the degrada-
tion of Arg-nsP4 but not of Tyr-nsP4 or Phe-nsP4. We found
that there is no lysine in the first 43 residues of nsP4 that is
required for its degradation, indicating that a more distal lysine
functions as the ubiquitin acceptor. Strict control of nsP4
concentration appears to be an important aspect of the virus life
cycle, since the concentration of nsP4 in infected cells is
regulated at three levels: translation of nsP4 requlres read-
through of an opal termination codon such that it is under-
produced; differential processing by the virus-encoded pro-
teinase results in temporal regulation of nsP4; and nsP4 itself
is a short-lived protein degraded by the ubiquitin-dependent
N-end rule pathway.
Sindbis virus, the prototype alphavirus, is an RNA animal
virus whose genome is 11,703 nucleotides long. Four non-
structural (ns) proteins, called nsPl-4 from their order in the
genome, are required for replication and transcription of viral
RNAs and are translated as polyprotein precursors from the
genomic RNA (1). We have previously reported that the
synthesis of nsP4, which is thought to be the viral RNA
polymerase (2-4), is regulated by at least two mechanisms in
Sindbis virus. First, nsP4 is produced only upon read-through
of an opal codon located at the 3' end of the nsP3 gene (5).
As a consequence, nsP4 and nsP4-containing polyproteins
are underproduced compared with nsP1, -2, and -3. The
second regulatory mechanism involves differential process-
ing of Sindbis polyprotein precursors by a set of virus-
encoded proteinases whose active site is located in the
C-terminal half of nsP2 (6, 7). Polyprotein precursors con-
taining nsP2 are all proteolytically active but differ in their
cleavage-site specificities: those containing nsP1 are unable
to cleave between nsP2 and nsP3, whereas only those con-
taining nsP3 cleave between nsP3 and nsP4 (8, 9). Appar-
ently, these differences lead to a temporal regulation of
processing such that very early in infection (0-2 hr after
infection) nsP4 is produced (9), whereas later in infection
polyprotein P34 is produced rather than nsP4 (9-11). We have
proposed that this temporal regulation ofthe relative amounts
of nsP4 and P34 is responsible for the cessation of minus-
strand RNA synthesis that occurs 3-4 hr after infection (9,
12, 13).
There are indications that a third regulatory mechanism
acts on nsP4. Many studies have found that Sindbis nsP4 is
metabolically unstable in infected cells (10, 11, 13), as is nsP4
of Semliki forest virus (14). Moreover, Sindbis nsP4 has also
been reported to be short-lived in rabbit reticulocyte lysates
(6, 8, 9). Wellink and van Kammen (15) suggested that nsP4
could be a target for the ubiquitin proteolytic pathway, a
major system for selective protein degradation (for reviews,
see refs. 16 and 17). Proteins to be eliminated by this pathway
are first conjugated to ubiquitin and subsequently degraded
by a large ATP-dependent protease. While a variety of
distinct degradation signals are thought to target proteins for
ubiquitin-dependent degradation, only one such signal has
been defined thus far. The presence of this signal, the N-end
rule-based degradation signal or N-degron, is manifested as
the N-end rule, which relates the in vivo half-life of a protein
to the identity of its N-terminal residue (18, 19). This degra-
dation signal comprises at least two distinct determinants: a
destabilizing N-terminal residue (18, 19) and a specific inter-
nal lysine residue (or residues) that serves as a multiubiquit-
ination site (20-22). N-terminal residues can be divided into
stabilizing (e.g., methionine, glycine, valine) and destabiliz-
ing (e.g., tyrosine, phenylalanine, leucine, isoleucine, aspar-
tic acid, glutamic acid, glutamine, arginine, lysine), depend-
ing on whether they confer a short half-life onto a protein that
contains the second (lysine) determinant of the N-degron
(18-22). Although the substrate selection process for this
pathway has been studied extensively, natural substrates for
this system have proven elusive. Recently, ubiquitin-
dependent degradation via unknown degradation signals has
been reported for a plant phytochrome (23), for several
nuclear oncoproteins (24), and for cyclin (25).
Sindbis nsP4 bears N-terminal tyrosine, a destabilizing
residue. Here, we provide evidence that in rabbit reticulocyte
lysates nsP4 is degraded by the ubiquitin-dependent N-end
rule pathway. The Sindbis virus RNA polymerase is thus the
first natural substrate of the N-end rule pathway to be
identified. The use ofpolyproteins is widespread among RNA
viruses. Targeting for degradation by a ubiquitin-dependent
pathway adds to the list of strategies by which these viruses
can regulate the intracellular levels of mature cleavage prod-
ucts.
Abbreviation: ns, nonstructural.
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MATERIALS AND METHODS
Plasmids. Plasmids pTotollO1 and pToto50 contain full-
length cDNA copies of the Sindbis virus genome (26).
pTotollOl.S (8) is a derivative ofpTotollO1 in which the opal
stop codon at the 3' end of the nsP3 gene was replaced by a
serine codon (11). pToto57 is a derivative ofpToto50 in which
a unique Xba I site has been introduced at position 54 of the
SIN genome (restriction sites are referred to by the position
in the Sindbis genome of the first nucleotide of the recogni-
tion sequence) (27). pToto.234 and pToto.123 from which
uncleaved proteinases can be produced by cell-free transcrip-
tion/translation, have been described (9). Cloning proce-
dures and standard molecular biological techniques were
performed as described (28).
Cassette Mutagenesis. To construct clone pToto.34, the
region spanning nucleotides 4101-5757 ofthe Sindbis genome
was amplified by PCR using the oligonucleotides CATG-
GCGCCGTCATACCGCACCAAAAG and GTCGACTAT-
CAGTATTCAGTCCTCCTGCTCCTG. The resulting frag-
ment was cut with Spe I (position 5262) and cloned into
pToto57, which had been cut with Xba I (blunt-ended with
Klenow) and Spe I. To eliminate the opal stop codon at the
3' end of the nsP3 gene, the Spe I (position 5262)/HindIII
(position 6267) fragment was replaced by the corresponding
fragment from pTotolll.S.
To construct pToto.34X, a fragment corresponding to
positions 5206-5739 of the Sindbis genome was produced by
PCR using the oligonucleotides ATGACAGTAGCGAAG-
GCTCACTTT and CCTTCTAGACCTGCGTCTACGTC-
TCTG (the introduced Xba I site is underlined) and digested
with Spe I and Xba I. A second fragment corresponding to
positions 5733-6280 was made by PCR using the oligonucle-
otides AGG IAGAAGGACTGAATACTGACTA and
AACTTCTAAQCUAGCGGGG and digested with Xba I
and HindIII (the restriction sites are underlined). The two
PCR fragments were ligated to pToto.34 digested with Spe I
and HindIII in a three-piece ligation. The sequence of the
Spe I/Xba I region was confirmed by nucleotide sequencing.
For construction ofM13mpl9.Ssp4, a PCR fragment span-
ning the region 5760-6280 of the Sindbis genome was pro-
duced using the oligonucleotides GTAGGTGGGAATAIJ-
TTTTCGACGG and AACTTCTAAGCTTAGCGGGG, cre-
ating a new Ssp I site (underlined) at position 5769. This
fragment was digested with HindIII and cloned into M13-
mp19 that had been prepared by digestion with Sma I and
HindIII, and the cloned fragment was sequenced in its
entirety.
Double-stranded oligonucleotides were synthesized that
spanned the region between the Xba I (residue 5730) and Ssp
I (residue 5769) sites of the Sindbis genome and contained an
Xba I overhang at the 5' end, a blunt 3' end, and substitutions
in the Tyr-1 codon of nsP4. These synthetic oligonucleotides
(the cassette) were joined to the HindIII/Xba I fragment of
pToto.34X and the Ssp I/HindIII fragment from M13-
mpl9.Ssp4 in a three-piece ligation.
Transcleavage Assays. Transcleavage assays were per-
formed as described (9). For inhibition experiments, bestatin
(to inhibit aminopeptidase activity) and 2 or 8 mM dipeptides
were included during the cleavage assay (19, 29).
RESULTS
Mutant Constructs. To test whether the metabolic stability
of nsP4 was a function of its N-terminal residue, we con-
structed plasmid pToto.34X, a derivative of the full-length
cDNA clone pTotollO1 of Sindbis virus (26) in which the
nsP1 and nsP2 genes (nucleotides 60-4101) have been de-
leted, the opal stop codon near the 3' end ofthe nsP3 gene has
been replaced with a serine codon, and an initiation codon
was inserted at the start of nsP3. To facilitate mutagenesis of
the 3/4 cleavage site, a unique Xba I site was created
upstream of the region encoding the cleavage site (note that
the introduction of this site did not alter the amino acid
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FIG. 1. Cassette mutagenesis. (A) Schematic of the Sindbis virus genome as it is present in plasmid pTotollOl, together with a schematic
of plasmid pToto.34X (p34X) derived from it. The in-frame opal termination codon present in wild-type virus (Op) was replaced by serine (S)
in p34X. (B) Sequence of the synthetic double-stranded cassette used to mutagenize the first position of nsP4 in p34X. The cassette spans the
region between newly createdXba I and Ssp I sites. The boxed AAT, encoding asparagine, that resulted in creation ofthe Ssp I site, is substituted
in the various cassettes by codons for tyrosine (the wild-type amino acid), methionine, phenylalanine, alanine, or arginine. The site of cleavage
between nsP3 and nsP4 is indicated by the asterisk. Nucleotides or amino acids altered during the constructions are shown in boldface. (C)
Three-fragment ligation between the cassette, the Ssp I/HindlIl fragment from M13mpl9.Ssp4 (Ssp4) and the HindIII/Xba I fragment of p34X,
which was used to produce the mutant p34X derivatives.
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sequence). The resulting nsP3/nsP4 genes are downstream of
the 5' noncoding region of the Sindbis genome (nucleotides
1-59) and an SP6 promoter (Fig. 1A). Transcription of this
plasmid with SP6 RNA polymerase and translation of the
transcribed RNA in reticulocyte lysates leads to production
of the P34 precursor. The N-terminal residue of nsP4 in P34
was changed by cassette mutagenesis, using cassettes illus-
trated in Fig. 1B and the three-piece ligation scheme depicted
in Fig. 1C. The double-stranded synthetic cassettes span the
region between two newly constructed restriction sites and
have a 5' Xba I overhang for directional insertion and a blunt
3' end. The three terminal nucleotides of the cassette (boxed)
encode the first amino acid of nsP4 (illustrated as AAT
encoding asparagine in Fig. 1B, resulting in the creation ofan
Ssp I site). These three nucleotides were changed in the
various cassettes such that the N terminus of nsP4 was either
tyrosine (the wild-type amino acid), phenylalanine, arginine,
methionine, or alanine.
Cleavage of P34 in Vitro. SP6 transcripts from constructs
encoding different N-terminal residues of nsP4 were trans-
lated in rabbit reticulocyte lysates in the presence of [35S]me-
thionine. The P34 species produced were incubated with
Sindbis P234 proteinase for 2 hr at 30°C (9) and examined for
cleavage at the 3/4 cleavage site. Cleavage was expected to
yield nsP4 derivatives differing only in their N-terminal
residue.
As shown in Fig. 2, no detectable cleavage occurred in the
absence of added P234 enzyme. There was a small amount of
nsP4 (but no nsP3) produced in the case of the Met' mutant,
which we assume arose by initiation at the N-terminal
methionine of nsP4. Quantitation of the results with a Mo-
lecular Dynamics computing densitometer showed that ini-
tiation at the 5' methionine to produce P34 occurred -50-fold
more frequently than initiation at the internal methionine.
Addition of P234 led to cleavage of all five P34 derivatives,
as shown by the production of nsP3 and nsP4 (Fig. 2). To
demonstrate that the site of cleavage was the same in each
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FIG. 2. Metabolic stability of nsP4 is a function of its N-terminal
residue. SP6 transcripts of p34X modified to contain different amino
acids in the first position of nsP4 were translated for 1 hr at 30°C in
rabbit reticulocytes in the presence of [35S]methionine. Translations
were terminated by addition of cycloheximide (6 mg/ml) and 1 mM
unlabeled methionine. Translates were then incubated with blank
reticulocyte lysate for 2 hr at 30°C (Left) or with translates of SP6
transcripts of plasmid pToto.234 as a source of P234 enzyme (9)
(Right). Lane T, translate of Sindbis RNA to mark the positions of
the various products. The N terminus of nsP4 in each construct is
indicated above the corresponding lane.
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FIG. 3. N-terminal sequence analysis of nsP4 and P34. P34 was
made and cleaved as described in the legend to Fig. 2, but the 100-.ul
translation reaction mixture contained 150 ,uCi of[ H]isoleucine (1 Ci
= 37 GBq) and cleavage was with P123 as enzyme, which appeared
to be more efficient than P234. Cleavage ofTyr'-nsP4 was conducted
in the presence of20mM Tyr-Ala to stabilize the nsP4 produced (29),
but the recovery of Tyr'-nsP4 was nonetheless low in comparison to
Met'-nsP4. Products were separated on 10%1 acrylamide gels and
microsequenced as described (30). Predicted sequences of P34 and
nsP4 are shown (31, 32).
case, N-terminal microsequencing was performed on prepa-
rations of wild-type and three mutant nsP4s, on P34, and on
two samples of nsP3 (Fig. 3; data not shown). This analysis
showed that the initiating methionine was removed from P34
and that in all cases cleavage of P34 occurred at the site
predicted from homology with Semliki forest virus (31).
To estimate the extent of cleavage, the bands in the film
shown in Fig. 2 and in lighter exposures of this gel were
quantitated and the molar ratio ofnsP3 to P34 was determined
from the known compositions of the proteins (32). From this,
the extent of cleavage of P34 was calculated and is shown in
Table 1 for each construct. The site GG*A (where the site of
Table 1. Cleavage and stability of nsP4 as a function of its
N terminus
N terminus % cleavage Molar ratio nsP4
of nsP4 of P34 nsP4/nsP3 ti/2, hr
Arg 18 0.25 0.3
Phe 12 0.32 0.4
Tyr 16 0.34 0.5
Ala 30 0.60 1.2
Met* 11 0.81 3.2
*Data have been corrected for nsP4 produced in the absence of P234
enzyme.
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cleavage is indicated by the asterisk) was cleaved about twice
as efficiently as the other sites, of interest since both the
nsP1/nsP2 and nsP2/nsP3 sites are GA*A. The other four
sites tested-GG*Y (the wild-type site), GG*F, GG*M, and
GG*R-were all cleaved with similar efficiency. We con-
clude that the P1' residue in the cleavage site (here the N
terminus of nsP4) has only modest effects on the efficiency of
cleavage.
The Metabolic Stability of nsP4 Is a Function of Its N-Ter-
minal Residue. Fig. 2 shows that the amounts of nsP4 found
after 2 hr of cleavage by the P234 proteinase depended on the
identity of its N-terminal residue. Small amounts of nsP4
(relative to nsP3) were found when the N terminus was
tyrosine, phenylalanine, or arginine, while larger amounts
were present when the N terminus was methionine or ala-
nine. These results were quantitated and the molar ratios of
nsP4 to nsP3 are given in Table 1.
The half-life of nsP4 in reticulocyte lysates can be esti-
mated from these data. The nsP4-producing proteinase is
limiting in this experiment, so that nsP3 and nsP4 should be
produced linearly with time. If we assume that nsP3 is stable
once produced, and that nsP4 is degraded with a first-order
rate constant k, then [nsP4]/[nsP3] = (1 e-k)/kt, where t
is the time, and the half-life of nsP4 is tl,2 =In2/k. Half-lives
calculated from these equations are given in Table 1; they are
probably underestimated because the rate of nsP4 production
appears to decrease after the first hour, presumably because
of inactivation ofthe processing proteinase (data not shown).
Degradation of nsP4 Is Inhibited by Dipeptides Bearing
Destabilizing N-Terminal Residues. Reiss et al. (29) and
Gonda etal. (19) have shown that the protein substrates of the
N-end rule pathway can be divided into distinct groups. Type
I substrates have N-terminal arginine, lysine, or histidine;
their ligation to ubiquitin and subsequent degradation can be
inhibited by dipeptides whose N terminus is one of these
three basic amino acids. Type II substrates have bulky,
uncharged N-terminal residues. For these substrates, dipep-
tides containing N-terminal leucine, tyrosine, phenylalanine,
or tryptophan have dramatic inhibitory effects, whereas
dipeptides bearing basic N-terminal residues have no effect.
Fig. 4 shows that the degradation of wild-type nsP4 bearing
an N-terminal tyrosine was inhibited by the dipeptides Tyr-
Ala, Phe-Ala, or Trp-Ala, but not by His-, Arg-, or Lys-Ala.
Similar results were obtained with nsP4 bearing N-terminal
phenylalanine. Conversely, when the N terminus of nsP4 was
arginine, its degradation was inhibited by His-, Arg-, or
Lys-Ala but not by Tyr-, Trp-, or Phe-Ala.
The results from several experiments using dipeptide in-
hibitors were quantitated, and the data are presented in Table
2. Inhibition is a function of both the concentration and the
identity of the N-terminal residue in a dipeptide relative to the
N-terminal residue of nsP4. Taken together, these results
(Figs. 2 and 4; Tables 1 and 2) indicate that the degradation
of nsP4 is carried out by the N-end rule pathway.
Lys'4 and Lys'5 of nsP4 Are Not Required for Its Degrada-
tion. The N-terminal residue is one essential determinant of
the N-degron, the other being a specific internal lysine
residue (or residues) (20-22). For example, dihydrofolate
reductase is metabolically stable irrespective of whether it
bears a destabilizing N-terminal residue (20), but a chimeric
protein consisting of dihydrofolate reductase coupled to a
43-residue N-terminal leader derived from an internal se-
quence of the lac repressor is metabolically unstable if it
bears a destabilizing N-terminal residue (20). Two specific
lysine residues within the leader segment (positions 15 and 17
from the N terminus) act as alternative acceptors for a
multiubiquitin chain; the presence of at least one of these
lysines is essential for degradation of dihydrofolate reductase
bearing a destabilizing N-terminal residue (20, 21). It was
proposed that a lysine residue in spatial proximity to the N
P334 (Y)
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FIG. 4. Stabilization ofnsP4 in reticulocyte lysates by dipeptides.
nsP4 containing N-terminal tyrosine (Left) or arginine (Right) was
produced by transcleavage as in Fig. 2. Either bestatin (BST) alone
orbestatin plus 8mM dipeptide (indicated at the top ofeach lane) was
present during incubation with P234.
terminus is required for degradation of a protein by the N-end
rule pathway. Interestingly, nsP4 contains two lysine resi-
dues in close proximity to the N-terminal tyrosine, at posi-
tions 14 and 15. Lys15 is conserved in all alphaviruses studied
except Middelburg virus. To test whether Lysl4-Lys" in
Sindbis nsP4 are required for degradation, they were substi-
tuted by Gln14-Argl5, the sequence found in Middelburg
virus. These mutations did not influence the metabolic in-
stability of nsP4 (data not shown). It appears that a more
distal lysine residue acts as ubiquitin acceptor in nsP4.
DISCUSSION
Cleavage of P34. We have found that P34 is a substrate for
cleavage in trans by the polyprotein proteinase P234 or P123.
Previously we showed that substitution of valine or glutamic
acid for the conserved glycine at the P2 position of the
cleavage site or of the alanine or glycine at the P1 position
renders the site noncleavable by the Sindbis nsP2 proteinase(8, 9). In this paper, we extend these results to show that the
proteinase shows little sensitivity to the residue at the P1'
position, at least for the nsP3/nsP4 site.
Recently, it was reported that for Semliki forest virus
cleavage at the 3/4 site is effected by a proteinase residing in
nsP4 (33). This is clearly not the case for Sindbis virus. First,
nsP3 and nsP4 were not detected upon mock digestion of P34(Fig. 2). Second, we have shown that deletions or even single
amino acid substitutions in nsP2 abolish processing of the 3/4
cleavage site, indicating that the active site of the enzyme
responsible for cleavage is in nsP2 (6, 8,9; E.G.S., R.J.d.G.,
Table 2. Inhibition of nsP4 degradation by dipeptides
N terminus
Tyr Tyr Phe Arg Arg
Inhibitor (2 mM) (8 mM) (8 mM) (8 mM) (8 mM)
None 0.20 0.22 0.28 0.20 0.19
His-Ala 0.19 0.25 0.27 0.60 0.58
Arg-Ala 0.22 0.25 0.29 0.59 0.63
Lys-Ala 0.18 0.31 0.30 0.76 0.74
Tyr-Ala 0.54 1.05 0.95 0.28 0.26
Trp-Ala 0.48 1.06 1.09 0.29 0.26
Phe-Ala 0.38 0.68 1.01 0.25 0.25
Results are nsP4/nsP3 molar ratio. The two results for arginine are
from independent experiments. Numbers in parentheses are inhibitor
concentration.
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R. Levinson, and J.H.S., unpublished data). It is possible
that Semliki forest and Sindbis viruses differ in this respect.
However, it is also possible that the nsP4-related polypep-
tides found upon in vitro translation of Semliki forest P34 (33)
were generated by internal initiation (e.g., at Met3" of Semliki
forest nsP4) rather than by proteolytic processing. As de-
scribed in Results, we have observed some synthesis of
Sindbis nsP4 by internal initiation in the case of the Tyr' --
Met' nsP4 mutant. Further characterization of the Semliki
forest virus system will be required to resolve this point.
nsP4 Is Degraded by the Ubiquitin-Dependent N-End Rule
Pathway. We have found that degradation of Sindbis nsP4 in
lysates of rabbit reticulocytes follows the N-end rule: the rate
of degradation of the nsP4 derivatives differed, depending on
their N-terminal residue. Specifically, the half-life of nsP4
bearing different N-terminal residues was found to decrease
in the order Met-nsP4 > Ala > Tyr 2 Phe > Arg. Using a
chimeric polypeptide, Gonda et al. (19) obtained the same
relative order of metabolic stabilities. Furthermore, the pat-
tern of inhibition of degradation by dipeptides is the same as
that previously found (19, 29). It seems clear that nsP4 is
degraded by the N-end rule pathway of ubiquitin-mediated
proteolysis. We propose that this pathway is also responsible
for the instability of nsP4 previously observed in infected
cells (10, 11, 13).
Specific internal lysine residues have also been found to be
required for degradation by the N-end rule pathway, by
functioning as acceptors for multiubiquitination (20, 21). In
the case of the chimeric protein studied by Varshavsky and
colleagues, the essential lysines were residues 15 and 17 from
the N terminus, within an artificial 43-residue leader segment
derived from the Escherichia coli lac repressor. The Sindbis
nsP4 sequence contains two lysine residues at almost the
same distance from the N terminus. However, we have
shown that these lysines are not essential for degradation; we
therefore assume that a more C-terminal lysine acts as
ubiquitin acceptor. It is noteworthy that a multisubunit
protein was recently described in which the destabilizing
N-end was not in the same polypeptide chain as the ubiquitin-
accepting lysine (22).
The importance of the metabolic instability of nsP4 for
Sindbis virus replication remains to be determined. We
presume that the virus has evolved to take advantage of the
ubiquitin system to regulate its life cycle. It is noteworthy
that nsP4 appears to be long-lived very early in infection (9)
and that a fraction of nsP4 produced upon shift to the
nonpermissive temperature in cells infected with Sindbis
mutant ts17 is also stable (13). One interpretation is that nsP4
is protected against degradation once incorporated in a
complex, whereas free nsP4 is rapidly degraded. This view is
consistent with recent results that nsP4 associated with
replication complexes is stable for several hours (34). A
similar phenomenon has been reported for other proteins that
form part of multiprotein complexes, such as ribosomal
proteins (35), keratin chains (36), and hemoglobin chains (37).
Viruses that express their genetic information as polypro-
teins have been found to use several strategies to regulate the
concentrations of the mature end products. These strategies
include synthesizing reduced amounts of the proteins by
requiring read-through of leaky stop codons or ribosomal
frameshifting (38, 39) and differential processing of polypro-
teins to produce different products (9, 40, 41). Selective
degradation of viral proteins by the ubiquitin-dependent
proteolytic pathway provides a regulatory mechanism that
may apply to a number of viruses. It is also possible that the
mechanism described here in which a viral polypeptide
produced by cleavage from a larger protein becomes a target
for the N-end rule pathway might be applicable to aspects of
cellular metabolism.
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